GSK GSK: viiv cabenuva (cab+rpv La) Superior to daily oral therapy in adolescents with hiv, lata week 96 results - press release
GSK GSK: viiv cabenuva (cab+rpv La) Superior to daily oral therapy in adolescents with hiv, lata week 96 results - press release